Home › Funds › Nantahala Capital Management, LLC › FULC
Nantahala Capital Management, LLC position in FULC
FULCRUM THERAPEUTICS INC · Health Care
Nantahala Capital Management, LLC reported holding 6,575,352 shares of FULC (FULCRUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$24.3M, representing 1.12% of its reported portfolio and ranking #27 among its reported holdings. Nantahala Capital Management, LLC has disclosed FULC holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nantahala Capital Management, LLC's FULC position evolved
Nantahala Capital Management, LLC first disclosed a stake in FULC in Q3 2024 at 4,777,912 shares (US$17.1M). The position peaked in Q4 2025 at 4,293,346 shares, worth US$48.6M. Across 9 filings, Nantahala Capital Management, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 6,575,352 shares valued at US$24.3M — an increase of 1,100,312 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2026 (shares fell 52% over the following quarter), a 80% increase in Q2 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 4.78M | $17.06M | New |
| Q4 2024 | 4.78M | $22.46M | Hold |
| Q1 2025 | 4.82M | $13.89M | Add |
| Q2 2025 | 4.29M | $29.50M | Reduce |
| Q3 2025 | 4.67M | $42.97M | Add |
| Q4 2025 | 4.29M | $48.56M | Reduce |
| Q1 2026 | 3.05M | $23.39M | Reduce |
| Q2 2026 | 5.48M | $20.04M | Add |
| Q3 2026 | 6.58M | $24.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FULC and 13F data
FULC (FULCRUM THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in FULC — the largest reported positions include EcoR1 Capital, LLC (US$24.0M), TANG CAPITAL MANAGEMENT LLC (US$23.9M), GSK plc (US$6.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FULC
- EcoR1 Capital, LLC 6.55M sh · $23.97M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 6.52M sh · $23.87M · Q2 2026
- GSK plc 1.79M sh · $6.61M · Q3 2026
More on Nantahala Capital Management, LLC
FAQ
How long has Nantahala Capital Management, LLC held FULC?
Nantahala Capital Management, LLC has disclosed FULC holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Nantahala Capital Management, LLC's current position in FULC?
As of Q3 2026, Nantahala Capital Management, LLC holds 6.58M shares of FULC (FULCRUM THERAPEUTICS INC), valued at $24.33M, representing 1.12% of its reported portfolio and ranking #27.
Has Nantahala Capital Management, LLC been buying or selling FULC?
In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC increased its position in FULC. The position peaked in Q4 2025 at 4.29M shares.
Which other funds hold FULC?
Other major institutional holders of FULC include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, GSK plc, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.